Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation

Gynecological Endocrinology

Volumn 22, Issue 8, 2006, Pages 465-470

  Artini, Paolo Giovanni ^a   Monti, Massimiliano ^a   Matteucci, Cristiana ^a   Valentino, Valeria ^a   Cristello, Francesca ^a   Genazzani, Andrea Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Angiogenesis; Basic fibroblast growth factor; In vitro fertilization; Polycystic ovary syndrome; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ANOVULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; HUMAN; OVARY FOLLICLE FLUID; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; THECA CELL;

CASE-CONTROL STUDIES; CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERTILIZATION IN VITRO; FIBROBLAST GROWTH FACTOR 2; FOLLICLE STIMULATING HORMONE; FOLLICULAR FLUID; HUMANS; OVULATION INDUCTION; OVUM; POLYCYSTIC OVARY SYNDROME; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33749490448     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590600906607     Document Type: Article

References (34)

1. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-2438.
2. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
3. Adams J, Polson DW, Abdulwahid N, Morris DV, Franks S, Mason HD, Tucker M, Price J, Jacobs HS. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985;ii: 1375-1378.
4. Franks S. The ubiquitous polycystic ovary. J Endocrinol 1991;129:317-319.
5. Eagleson CA, Bellows AB, Hu K, Gingrich MB, Marshall JC. Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids. J Clin Endocrinol Metab 2003;88:5158-5162.
6. Battaglia C, Artini PG, D'Ambrogio G, Genazzani AD, Genazzani AR. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 1995;172:108-113.
7. Zaidi J, Campbell S, Pittrof R, Kyei-Mensah A, Shaker A, Jacobs HS, Tan SL. Ovarian stromal blood flow in women with polycystic ovaries - a possible new marker for diagnosis? Hum Reprod 1995;10:1992-1996.
8. Aleem FA, Predanic M. Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease. Fertil Steril 1996;65: 510-516.
9. Agrawal R, Conway G, Sladkevicius P, Tan SL, Engmann L, Payne N, Bekir J, Campbell S, Jacobs H. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril 1998;70:651-658.
10. Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril 2001;76:326-331.
11. Yamamoto S, Konishi I, Tsuruta Y, Nanbu K, Mandai M, Kuroda H, Matsushita K, Hamid AA, Yura Y, Mori T. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in human ovary. Gynecol Endocrinol 1997;11:371-381.
12. Gospodarowicz D, Plouet J, Fujii DK. Ovarian germinal epithelial cells respond to basic fibroblast growth factor and express its gene: implications for early folliculogenesis. Endocrinology 1989;125:1266-1276.
13. Reynolds LP, Grazul-Bilska AT, Redmer DA. Angiogenesis in the female reproductive organs: pathological implications. Int J Exp Pathol 2002;83:151-163.
14. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of polypeptides. Endocr Rev 1992;13:18-32.
15. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor as a secreted angiogenic mitogen. Science 1989;246:1306-1309.
16. Lee A, Christenson LK, Patton PE, Burry KA, Stouffer RL. Vascular endothelial growth factor production by human luteinized granulosa cells in vitro. Hum Reprod 1997;12: 2756-2761.
17. Artini PG, Fasciani A, Monti M, Luisi S, D'Ambrogio G, Genazzani AR. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Fertil Steril 1998;70:560-564.
18. Agrawal R, Tan SL, Wild S, Sladkevicius P, Engmann L, Payne N, Bekir J, Campbell S, Conway G, Jacobs H. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril 1999;71:287-293.
19. Ferrara N, Davis Smith T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:14-25.
20. Van Blerkom J, Antezak M, Schrader R. The development potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod 1997;12:1047-1055.
21. Agrawal R, Sladkevicius P, Engmann L, Conway G, Payne N, Bekis J, Tan SL, Campbell S, Jacobs HS. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod 1998;13:651-655.
22. Amin AF, Abd el-Aal DE,Darwish AM,Meki AR Evaluation of the impact of laparoscopic ovarian drilling onDoppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovarian syndrome. Fertil Steril 2003;79:938-941.
23. Agrawal R, Jacobs H, Payne N, Conway G. Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries. Fertil Steril 2002; 78:1170-1171.
24. Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy L, Klepper R, Gospodarowicz D, Bohlen P, Guillemin R. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 1985;82:6507-6511.
25. Abraham JA, Mergia A, Whang JL, Tumolo A, Friedman J, Hjerrild KA, Gospodarowicz D, Fiddes JC. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 1986;233: 545-548.
26. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 1987;8:95-114.
27. Yamamoto S, Konishi I, Nanbu K, Komatsu T, Mandai M, Kuroda H, Matsushita K, Mori T. Immunohistochemical localization of basic fibroblast growth factor (bFGF) during folliculogenesis in the human ovary. Gynecol Endocrinol 1997;11:223-230.
28. Adashi EY, Resnick CE, Croft CS, May JV, Gospodarowicz D. Basic fibroblast growth factor as regulator of ovarian granulosa cell differentiation: a novel non-mitogenic role. Mol Cell Endocrinol 1988;55:7-14.
29. Oury F, Darbon JM. Fibroblast growth factor regulates the expression of luteinizing hormone receptors in cultured rat granulosa cell. Biochem Biophys Res Commun 1988;156: 634-643.
30. Seli E, Zeyneloglu HB, Senturk LM, Bahtiyar OM, Olive DL, Arici A. Basic fibroblast growth factor: peritoneal and follicular fluid levels and its effect on early embryonic development. Fertil Steril 1998;69:1145-1148.
31. Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, Marme D, Breckwoldt M. Human chorionic gonadotropindependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995;80:1967-1971.
32. McClure N, Healy DL, Rogers PA, Sullivan J, Beaton L, Haning RV Jr, Connolly DT, Robertson DM. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994;344: 235-236.
33. Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ, Yeo KT. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 1996;65:552-555.
34. Geva E, Jaffe RB, Edward WE. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000;74:424-438.